Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Vitamin C for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation From Deceased Donors

NCT05754242 is registered in ClinicalTrials.gov with Hospital Universitario Ramon y Cajal as lead sponsor.

NCT NCT05754242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05754242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Vitamin C for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation From Deceased Donors
Lead sponsor
Hospital Universitario Ramon y Cajal
Phase
Phase 2
Overall status
Unknown status
Start date
November 17, 2020
Completion date
July 30, 2023
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ascorbic acid, liver transplantation, postreperfusion syndrome